Addition of ATG to Myeloablative Haplo Conditioning with Post-Transplantation Cyclophosphamide Might Decrease the Risk of Gvhd and TRM without Increasing the Risk of Relapse

被引：5

作者：

Al Dawsari, Ghuzayel ^{[1
]}

Hassanein, Mona Fawzy Ramadan ^{[1
]}

Rasheed, Walid ^{[1
]}

Almohareb, Fahad ^{[1
]}

Chaudhri, Naeem A. ^{[1
]}

Alsharif, Fahad ^{[1
]}

Al Zahrani, Hazza ^{[1
]}

Mohamed, Said Y. ^{[1
]}

Hanbali, Amr ^{[1
]}

Ahmed, Syed Osman ^{[1
]}

Shaheen, Marwan ^{[1
]}

Alfraih, Feras ^{[1
]}

Hashmi, Shahrukh ^{[1
]}

Al Hashim, Noura ^{[1
]}

Ahmed, Shad ^{[1
]}

el Gohary, Ghada ^{[1
]}

Chebbo, Wahiba ^{[1
]}

Mannan, Abdul ^{[1
]}

Alsermani, Maamoun ^{[1
]}

Anjum, Farhan ^{[1
]}

Almahayni, Muhamad Hitham ^{[1
]}

Aljurf, Mahmoud ^{[1
]}

El Fakih, Riad O. ^{[1
]}

机构：

[1] King Faisal Specialist Hosp & Res Ctr, Riyadh, Saudi Arabia

来源：

BLOOD | 2016年 / 128卷 / 22期

关键词：

D O I：

10.1182/blood.V128.22.5871.5871

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

5871

引用

页数：6

共 49 条

[1] Post Transplant Cyclophosphamide (PTCy) with Anti-Thymocyte Globulin (ATG) As Gvhd Prophylaxis Is Effective in Haploidentical Peripheral Stem Cell Transplantation and without Increasing Risk of Relapse
Lin, Ching Chan
Chen, Tzu Ting
Lo, Wen Jyi
Lein, Ming Yu
Hiseh, Ching Yun
Lin, Chen Yuan
Bai, Li-Yuan
Chiu, Chang-Fang
Lin, Che Hung
Yeh, Su-Peng
[J]. BLOOD, 2017, 130
[2] Myeloablative Conditioning Haploidentical Stem Cell Transplantation (MAC-HAPLO) with Post-Transplant Cyclophosphamide (PTCy) As GvHD Prophylaxis in High Risk Leukemias/Myelosdysplastic Syndromes (MDS): Geth Experience
Gayoso, Jorge
Balsalobre, Pascual
Kwon, Mi
Herrera, Pilar
Bermudez, Arancha
Sampol, Antonia
Jimenez, Santiago
Lopez-Corral, Lucia
Serrano, David
Montesinos, Pau
Pascual, Maria-Jesus
Heras, Inmaculada
Bento, Leyre
Varela, Rosario
Humala, Karem
Zabalza, Amaya
Laiglesia, Almudena
Bastos-Oreiro, Mariana
Perez-Corral, Ana
Martinez-Laperche, Carolina
Diez-Martin, Jose Luis
[J]. BLOOD, 2016, 128 (22)
[3] Unmanipulated haplo-identical bone marrow transplantation (following non-myeloablative conditioning) for advanced Hodgkin's lymphoma using post-transplantation cyclophosphamide
Raiola, A. M.
Dominietto, A.
van Lint, M. T.
Annunziata, S.
Gualandi, F.
Castagna, L.
Todisco, E.
Santoro, A.
Bramanti, S.
Sarina, B.
Bacigalupo, A.
[J]. BONE MARROW TRANSPLANTATION, 2011, 46 : S246 - S246
[4] Myeloablative Haploidentical Stem Cell Transplantation (MAC-HAPLO) With Post-Transplant Cyclophosphamide (PTCy) As Gvhd Prophylaxis In High Risk Leukemias/Myelosdisplastic Syndromes (MDS)
Gayoso, J.
Balsalobre, P.
Kwon, M.
Sampol, A.
Montesinos, P.
Serrano, D.
Herrera, P.
Pascual, M. J.
Bermudez, A.
Castilla-Llorente, C.
Bento, L.
Champ, D.
Perez-Corral, A.
Buces, E.
Diez-Martin, J. L.
[J]. BONE MARROW TRANSPLANTATION, 2015, 50 : S270 - S270
[5] HAPLOIDENTICAL TRANSPLANTATION WITH CYCLOPHOSPHAMIDE POST TRANSPLANT AND MYELOABLATIVE CONDITIONING IN THE TREATMENT OF HIGH RISK NEOPLASMS: GETH EXPERIENCE
Jorge, Gayoso
Pascual, Balsalobre
Pilar, Herrera
Lucia, Lopez-Corral
Leyre, Bento
Mi, Kwon
Carmen, Martin
David, Serrano
Almudena, Laiglesia
Santiago, Jimenez
Pau, Montesinos
Karen, Humala
Arancha, Bermudez
Jesus, Pascual Maria
Ana, Perez-Corral
Diana, Champ
Inmaculada, Heras
Amaya, Zabalza
Ismael, Buno
Montserrat, Rovira
Antonio, Perez-Simon J.
Luis, Diez-Martin J.
[J]. HAEMATOLOGICA, 2016, 101 : 42 - 43
[6] Post-transplantation cyclophosphamide versus low dose ATG FRESENIUS IN GVHD prophylaxiS: Similar graft versus host disease and relapse-free survival
Fernandez Martinez, Cristina
Bermudez Rodriguez, Arancha
Garcia Avila, Sara
Cabero Martinez, Almudena
Yanez Sansegundo, Lucrecia
Lopez Duarte, Monica
Mora Barrios, Joan Manuel
Gonzalez Romero, Yolanda
Fernandez Luis, Sara
Gomez Lamas, David
Insunza Gaminde, Andres
Romon, Inigo
Luis Arroyo, Jose
Richard Espiga, Carlos
Ocio San Miguel, Enrique Maria
Colorado Araujo, Mercedes
[J]. BONE MARROW TRANSPLANTATION, 2019, 54 : 93 - 94
[7] Risk-adapted GVHD prophylaxis with post-transplantation cyclophosphamide in adults after related, unrelated, and haploidentical transplantations
Moiseev, Ivan S.
Pirogova, Olga V.
Alyanski, Alexandr L.
Babenko, Elena V.
Gindina, Tatyana L.
Darskaya, Elena I.
Slesarchuk, Olga A.
Bykova, Tatyana A.
Chukhlovin, Alexei B.
Pevtcov, Dmitrii E.
Bondarenko, Sergey N.
Afanasyev, Boris V.
[J]. EUROPEAN JOURNAL OF HAEMATOLOGY, 2018, 100 (05) : 395 - 402
[8] Myeloablative Haploidentical Stem Cell Transplantation (MAC-HAPLO) with Post-Transplant Cyclophosphamide (PT-CY) As GVHD Prophylaxis in High Risk Leukemias/Myelosdisplastic Syndromes (MDS)
Gayoso, Jorge
Balsalobre, Pascual
Kwon, Mi
Sampol, Antonia
Montesinos, Pau
Serrano, David
Herrera, Pilar
Jesus Pascual, Maria
Bermudez, Arancha
Castilla-Llorente, Cristina
Bento, Leyre
Champ, Diana
Perez-Corral, Ana
Buces, Elena
Luis Diez-Martin, Jose
[J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (02) : S186 - S186
[9] Sequential HLA-haploidentical transplantation utilizing post-transplantation cyclophosphamide for GvHD prophylaxis in high-risk and relapsed/refractory AML/MDS
Fraccaroli, Alessia
Prevalsek, Dusan
Fritsch, Susanne
Haebe, Sarah
Buecklein, Veit
Schulz, Christoph
Hubmann, Max
Stemmler, Hans-Joachim
Ledderose, Georg
Hausmann, Andreas
Schmid, Christoph
Tischer, Johanna
[J]. AMERICAN JOURNAL OF HEMATOLOGY, 2018, 93 (12) : 1524 - 1531
[10] POST-TRANSPLANTATION CYCLOPHOSPHAMIDE-BASED GVHD PROPHYLAXIS AFTER FLU-TBI MYELOABLATIVE CONDITIONING IS ASSOCIATED WITH FAVORABLE OUTCOMES IN ADULT PATIENTS WITH ALL TREATED WITH CONTEMPORARY INDUCTION REGIMENS
Bambace, Nadia
Linhares, Yuliya P. L.
Perez, Ariel Perez
Pharm, Tiba Al Sagheer
Zahra, Talia
Rubens, Muni B.
[J]. BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 265 - 266

← 1 2 3 4 5 →